This article is available to subscribers. Subscribe now. Already have an account? Sign in

EditorialFree Preview

The Closing Argument for Surgical Left Atrial Appendage Occlusion

List of authors.
  • Richard L. Page, M.D.

It is widely accepted that the increased risk of stroke among patients with atrial fibrillation is substantially due to embolization of thrombi that develop in the left atrial appendage. On the basis of multiple randomized trials showing that the risk of stroke is reduced with oral anticoagulation therapy among high-risk patients with nonvalvular atrial fibrillation, clinical practice guidelines provide the strongest level of recommendation for oral anticoagulation in these patients, as guided by CHA2DS2-VASc1,2 or CHADS-653 risk scores. In comparison with the robust data that underlie the recommendation for oral anticoagulation, the strategy of percutaneous occlusion of the left atrial . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.

This editorial was published on May 15, 2021, at NEJM.org.

Author Affiliations

From the Division of Cardiovascular Medicine, Department of Medicine, Robert Larner, M.D., College of Medicine, University of Vermont, Burlington.